Harnessing bioinformatics to find new drug combinations for breast cancer
The bimonthly magazine Clinical OMICs interviews Patrick Aloy, ICREA researcher and leader of the Structural Bioinformatics and Network Biology lab at IRB Barcelona, about his study published in the journal Cancer Research. Patrick Aloy talks about his work as a leader of team that uses bioinformatics approaches to uncover new drug combinations for the treatment of breast cancer.
The seventh video in the series Meet Our Scientists, "Networks of Life", presents the work performed by Patrick Aloy. Watch the video (Subtitles available in Spanish, Catalan and English).
Related content
News
The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero y Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells. This information can then be used to design therapeutic targets and to limit the capacity of these cells to metastasize. “This is a groundbreaking approach to tackle metastasis in this kind of cancer,” says Gomis.
The funded project will address the development of metastasis in breast cancer.
The grant, which is specifically for research into breast cancer, has been given by the foundation, in collaboration with Mango.
Fero is a private foundation that promotes translational cancer research in Spain.
On 19 October, World Breast Cancer Day is celebrated to remember the commitment of the entire society in the fight against this disease -the most common tumour in western women.
